|
00 CANCELLED EVENTS
|
00 DELAYED EVENTS
|
|
00 DIGITALISED EVENTS
|
00 AS PLANNED EVENTS
|
Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Collaboration is a huge topic in healthcare today. The industry is evolving extremely fast, and while that brings with it plenty of opportunity, it also creates new challenges.
Discover how AI is transforming the pharma commercial strategy. Unlock real-time insights & actions from data. Click here for more.
IN THIS ISSUE: The 2024 US Presidential race is nearing its end, but what does that mean for pharma?
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
In this podcast episode, Jesse Mendelsohn and Nicole Raleigh discuss what the future might hold for pharma under a second Trump Administration
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
9th Liquid Biopsy for Precision Oncology Summit | February 18-20, 2025 | San Diego, CA | FREE* to Attend for Biopharma
The pivotal shift in biopharma priorities is steering towards enhancing sustainability measures for drug development.
